| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_011d93b2fd61caa2facac5ac84a40549 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-402
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2013-4708
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-216 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-352
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F13-472
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7023
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L15-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L15-44 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F13-472
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06 |
| filingDate |
2018-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a79ea8d54cb64848ca21b3da3c7f59ae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_517193c0ebbc9d751061a0a97331e657
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d55b7133ac88ba1514151ebd5eabe38 |
| publicationDate |
2019-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2019052303-A1 |
| titleOfInvention |
Composition containing cannabidiol and/or secondary cannabinol and its application in treating dysmenorrhea |
| abstract |
The invention relates to a composition for preventing and / or treating dysmenorrhea in women. The composition contains cannabidiol and / or cannabidivarin, a transdermal activator and a carrier. The mass ratio of cannabidiol and / or cannabidivarin to the transdermal activator is 1: 0.1-0.8. The composition can relieve dysmenorrhea in women, and can be used to prepare feminine hygiene products to prevent and / or treat dysmenorrhea in women. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102020107937-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4054540-A4 |
| priorityDate |
2017-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |